AzTrials
AzTrials

SinusitisHSINCT01717274

Hot Saline Irrigation Study

A study testing Hot saline irrigation in people with Sinusitis, run by St. Paul's Hospital, Canada at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many methods have been used to reduce bleeding during sinus surgery (FESS) in order to allow for the best surgical view and to reduce risk while in surgery. Warm irrigation fluid is believed to accelerate the clotting mechanism in the human body. Read more about this study

Who is it for?
Ages 19 to 75 years
Conditions the study is for
Sinusitis
What is being tested?
Hot saline irrigation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteCanada
Study dates
Nov 2012to Apr 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with American Society of Anesthesiologist (ASA) classification <2
  • Patients with chronic or recurrent sinusitis (as defined by the American Academy of Otolaryngology) with or without nasal polyposis refractory to medical treatment

Who cannot join

  • Patients with a history of coagulation disorders
  • Patients with severe ischemic heart disease (IHD), pulmonary and renal disease
  • Patients with tumours or vascular anomalies
  • Patients with cystic fibrosis, allergic fungal sinusitis and Wegener's granulomatosis
  • Patients who are unable to speak, read and write English

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • E.N.T. Clinic, St. Paul's Hospital

    Vancouver, British Columbia, V6Z 1Y6

Other trials in Canada

About this study

Official title: Hot Saline Irrigation vs Room Temperature Saline Irrigation in the Control of Intraoperative Bleeding During Functional Endoscopic Sinus Surgery (FESS)

Many methods have been used to reduce bleeding during sinus surgery (FESS) in order to allow for the best surgical view and to reduce risk while in surgery.

Warm irrigation fluid is believed to accelerate the clotting mechanism in the human body. The investigators would like to determine if hot saline irrigation (HSI) compared to room temperature saline irrigation (RTSI) can control bleeding during FESS.

The hypothesis is that HSI is more effective than RTSI in reducing intraoperative bleeding during FESS.

Read the detailed description

Background and Significance:

Functional endoscopic sinus surgery (FESS) is a minimally invasive surgery to relieve obstruction and to facilitate drainage and ventilation of the paranasal sinuses. It is a common rhinologic procedure that is safe, comfortable and allows quick patient recovery. As the paranasal sinuses have complex anatomy and are surrounded by important structures, there are risks of serious orbital and intracranial injuries. These risks are increased if visualization during surgery is impaired with bleeding. The endoscopically magnified operative field in sinus surgery makes even a small amount of bleeding a potentially significant hindrance. Hence, numerous methods to reduce intraoperative bleeding during FESS have been described. These include the use of preoperative nasal decongestion (such as topical oxymetazoline, cocaine and adrenaline), preoperative oral tranexamic acid, intraoperative injection of the lateral nasal wall with lidocaine and adrenaline and intraoperative controlled hypotension (using total intravenous anaesthesia and B-blockers) as well as the head up position during surgery. The success rates of these methods have been variable and some of these techniques are associated with adverse cardiopulmonary events.1-7 Visual compromise secondary to bleeding remains a problem during FESS and the ideal method to reduce intraoperative bleeding remains elusive.

Hot water irrigation (HWI) was first used by obstetricians in controlling postpartum bleeding over a hundred years ago.8 Its use in the control of intractable epistaxis was first described by Guice in 1878.9 In a histological study of nasal mucosa of rabbits irrigated with hot water, Stangerup and Thomsen found that temperatures of up to 50 degrees Celsius produces vasodilation and edema of the nasal mucosa without necrosis. They postulated that mucosal edema leads to compression of the bleeding vessels and may trigger and accelerate the clotting cascade.10 Stangerup et al found that in their series of 122 patients, posterior epistaxis was controlled in 55% of patients treated with HWI compared to 44% in the group treated with nasal packing.11 Novoa and Schlegel-Wagner subsequently showed that 82% of patients with intractable posterior epistaxis can be arrested with HWI.12 HWI has also led to reduced hospital stay, reduced number of surgical procedures, less pain and less nasal trauma. As continuous exposure of the nasal mucosa to pure water for 30 minutes has been shown by an in-vitro study to cause severe damage to the epithelial cells, we have decided to use hot normal saline in our study.13 Although hot saline irrigation (HSI) has been used in FESS and endoscopic skull base surgery, there are currently no reports in the English literature on its effectiveness.

Aim:

To assess the effectiveness of hot saline irrigation (HSI) compared to room temperature saline irrigation (RTSI) in the control of intraoperative bleeding during FESS.

Hypothesis:

HSI is more effective than RTSI in reducing intraoperative bleeding during FESS

Experimental design and methods:

Target population:

Patients are recruited from the St. Paul's Sinus Centre at St. Paul's hospital in Vancouver, Canada.

Sample size: 60 patients (30 patients in each arm)

Preoperative data collection:

The following data is collected preoperatively:

  1. Patient's demographics (age, sex, race)
  2. Preoperative Lund and Mackay Score
  3. Presence of polyps

Research design:

Double blind randomized control trial

Preoperative:

All patients are treated with a one-week course of prednisone 20mg once a day and oral antibiotics (clavulin or clindamycin if penicillin) prior to surgical intervention.

Intraoperative:

Procedure:

Using a closed envelope system, patients enrolled in the study are randomized to receive either HSI (defined as temperatures of 45-50 degrees Celsius) or RTSI (defined as temperature of the operating room). Both the patient and the surgeon are blinded to the temperature of the irrigation fluid used during surgery. After randomization, a nominated research assistant will receive instructions to prepare the hot or room temperature saline solution.

Experimental arm:

Hot saline is prepared by first placing 2 litres of sterile normal saline (0.9%) into a basin (IntraTemp Therma BasinTM) that is wrapped in a sterile disposable drape (IntraTemp Therma Basin DrapeTM). The basin is then placed in a medical grade warmer (IntraTemp Fluid Warming SystemTM). The warmer is set to heat the saline up to a temperature of 50 degrees Celsius. An external digital thermometer is placed in the saline at all times to ensure that the temperature is between 45-50 degrees.

Control arm:

Room temperature saline is prepared in the same manner except that the warmer is switched off and the temperature of the saline in the basin is left to equilibrate to the temperature of the operating room.

In both arms, a 60 cc syringe attached to an olive tip long curve suction is used to draw the irrigation fluid from the basin. The surgical field is flushed with 20 cc of hot or room temperature saline at five minutes intervals by a research assistant. Additional flushes with hot or room temperature saline can be administered in between the five-minute intervals upon request by the surgeon. The degree of bleeding in the surgical field is scored by the operating surgeon using the validated Boezaart and van der Merwe Grading System14. This 0 to 5-point scale will be used to outline the amount of suction required to rid the area of blood disrupting vision. A score of 0 is given for an area with no bleeding, 1 for slight bleeding with no suction required, 2 for slight bleeding requiring suction, 3 for moderate bleeding which improves for several seconds once suction has occurred, 4 for moderate bleeding which restarts directly after suctioning and 5 for severe bleeding which occurs faster then can be removed14. Surgical field of view will be assessed and scored every 15 minutes for the duration of the surgery. At the end of the procedure, the estimated blood loss is calculated by subtracting the total amount of irrigation fluid used from the fluid in the suction bottle. The total amount of HSI or RTSI administered and time of surgery are documented.

Surgery:

Patients are placed under general anesthesia and intubated with endotracheal tubes. Immediately after general anesthesia, both nasal cavities are packed with neuropatties soaked with Otrivin (xylometazolin 0.05%). The patients' heads are elevated 15 degrees up. The image guided system is set up and each nasal cavity is examined with a 0 degree endoscope. A 10 cm merocel is cut into a third of its normal size and inserted to the back of the nasopharynx, to prevent blood from flowing into the oropharynx and larynx. An artery forceps is clipped onto the merocel string to prevent dislodgement of the merocel into the larynx or oropharynx. FESS is performed using the technique described by Messerklinger15 and with a microdebrider when deemed necessary. The extent of the operation depends on the severity of the disease seen on the pre-operative CT scan of the paranasal sinus.

Data collection and analysis:

This is a pilot study; hence the statistical analysis will be completed at the end of the study.

Clinically significant change in intra-operative bleeding will be defined as a change in Boezaart scoring by 20%, or one point in relation to the scale. All data collected for this study will be gathered in a password protected Microsoft Excel spreadsheet file. Each patient will be assigned unique identification allowing for no patient data to be recorded. The Microsoft Excel database will include:

  • Age
  • Sex
  • Pre-existing health conditions
  • Current medications
  • Lund-Kennedy CT score
  • CRS with or without polyposis
  • Primary or revision surgery
  • Anesthesia infusion
  • MAP (15 minute intervals)
  • Pulse rate (15 minute intervals)
  • Endoscopic surgical field scores (15 minute intervals)
  • Intra-operative complications
  • Microdebrider usage
  • Total blood loss
  • Total time of surgery
  • Total saline irrigation used

Risk:

The use of nasal irrigation of up to 50 degrees Celsius have been shown to be safe on the epithelium of rabbit nasal mucosa studied in-vitro.10 In addition, studies have shown that irrigation of the human nasal mucosa with temperatures of up to 50 degrees Celsius did not result in any complications.11,12 Hot saline irrigation has been widely used for skull base and endoscopic sinus surgery for many years with no known reported complication in the English literature.

Difficulties and limitation:

Patient recruitment:

Based on the surgical volume at St Paul's Sinus Centre, we do not foresee any difficulties in achieving the target sample size. The St Paul's Sinus Centre is actively involved in research. Many of our patients are aware of this and are keen to participate in and contribute to medical research.

Achieving the desired temperature:

The exact temperature of 50 degrees Celsius is difficult to achieve. Hence we defined our HSI with a range of temperature of 45-50 degrees Celsius

Conditions
Sinusitis
Being tested
Hot saline irrigation
Keywords
Functional Endoscopic Sinus Surgery, Hot water irrigation
Medical subject headings
Sinusitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hot saline irrigationProcedure or surgery

    Also called HSI

    The surgical field is flushed with 20 cc of hot saline (45-50 degrees Celsius) at five minutes intervals. This is in contrast to the standard of care, room temperature (20-25 degrees Celsius) saline irrigation.

Study groups in NCT01717274
Study groupRoleWhat they receive
Hot saline irrigationExperimentalHot saline is prepared by first placing 2 litres of sterile normal saline (0.9%) into a basin (IntraTemp Therma BasinTM) that is wrapped in a sterile disposable drape (IntraTemp Therma Basin DrapeTM). The basin is then placed in a medical grade warmer (IntraTemp Fluid Warming SystemTM). The warmer is set to heat the saline up to a temperature of 50 degrees Celsius. An external digital thermometer is placed in the saline at all times to ensure that the temperature is between 45-50 degrees.
Receives: Procedure: Hot saline irrigation
Room temperature saline irrigationNo interventionRoom temperature saline is prepared in the same manner as the experimental arm except that the warmer is switched off and the temperature of the saline in the basin is left to equilibrate to the temperature of the operating room.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Boezaart and van der Merwe intraoperative surgical field scale

    The Boezaart intra-operative surgical field scale will be used to grade the level of bleeding during surgery. This 0 to 5-point scale will be used to outline the amount of suction required to rid the area of blood disrupting vision. A score of 0 is given for an area with no bleeding, 1 for slight bleeding with no suction required, 2 for slight bleeding requiring suction, 3 for moderate bleeding which improves for several seconds once suction has occurred, 4 for moderate bleeding which restarts directly after suctioning and 5 for severe bleeding which occurs faster then can be removed

    Measured: Every 15 minutes for the duration of surgery..

Secondary outcomes (1)
  1. Total Estimated Blood Loss

    Total blood loss will be recorded over the duration of surgery.

    Measured: Duration of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2012 (estimated)
  2. Study startNov 2012
  3. Primary completionMar 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01717274
Sponsor's protocol ID
HSI-2012
Acronym
HSI
Status last verified
Apr 2016
First submitted
26 Oct 2012
Last updated
14 Apr 2016
Results posted
No
Data monitoring committee
No

Publications

  • Riegle EV, Gunter JB, Lusk RP, Muntz HR, Weiss KL. Comparison of vasoconstrictors for functional endoscopic sinus surgery in children. Laryngoscope. 1992 Jul;102(7):820-3. doi: 10.1288/00005537-199207000-00012.

    PubMed 1614253
  • Yaniv E, Shvero J, Hadar T. Hemostatic effect of tranexamic acid in elective nasal surgery. Am J Rhinol. 2006 Mar-Apr;20(2):227-9.

    PubMed 16686395
  • Tirelli G, Bigarini S, Russolo M, Lucangelo U, Gullo A. Total intravenous anaesthesia in endoscopic sinus-nasal surgery. Acta Otorhinolaryngol Ital. 2004 Jun;24(3):137-44.

    PubMed 15584584
  • Higgins TS, Hwang PH, Kingdom TT, Orlandi RR, Stammberger H, Han JK. Systematic review of topical vasoconstrictors in endoscopic sinus surgery. Laryngoscope. 2011 Feb;121(2):422-32. doi: 10.1002/lary.21286. Epub 2011 Jan 13.

    PubMed 21271600
  • Stangerup SE, Dommerby H, Siim C, Kemp L, Stage J. New modification of hot-water irrigation in the treatment of posterior epistaxis. Arch Otolaryngol Head Neck Surg. 1999 Jun;125(6):686-90. doi: 10.1001/archotol.125.6.686.

    PubMed 10367928
  • Novoa E, Schlegel-Wagner C. Hot water irrigation as treatment for intractable posterior epistaxis in an out-patient setting. J Laryngol Otol. 2012 Jan;126(1):58-60. doi: 10.1017/S002221511100243X. Epub 2011 Sep 5.

    PubMed 21888749
  • Javer AR, Gheriani H, Mechor B, Flamer D, Genoway K, Yunker WK. Effect of intraoperative injection of 0.25% bupivacaine with 1:200,000 epinephrine on intraoperative blood loss in FESS. Am J Rhinol Allergy. 2009 Jul-Aug;23(4):437-41. doi: 10.2500/ajra.2009.23.3339.

    PubMed 19671263
  • Gan EC, Alsaleh S, Manji J, Habib AR, Amanian A, Javer AR. Hemostatic effect of hot saline irrigation during functional endoscopic sinus surgery: a randomized controlled trial. Int Forum Allergy Rhinol. 2014 Nov;4(11):877-84. doi: 10.1002/alr.21376. Epub 2014 Aug 18.

    PubMed 25137523

Questions about this trial

What is this clinical trial studying?

A study testing Hot saline irrigation in people with Sinusitis, run by St. Paul's Hospital, Canada at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Boezaart and van der Merwe intraoperative surgical field scale (time frame: Every 15 minutes for the duration of surgery..). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01717274, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in